05Nov 2018

The Challenge: There is no knows cure for Alzheimer’s Disease The challenge is to define a set of biomarkers that are associated with the early identification of AD. By identifying biomarkers for the early identification of AD, we can help in the selection of participants for clinical trials, reducing their cost, and increasing their benefit. […]